Fig. 1From: Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusionTime to achievement of 20/40 or better vision by baseline best-corrected visual acuity. Excludes 22 (10.9%) patients with 20/40 or better vision at baseline. ETDRS, Early Treatment Diabetic Retinopathy StudyBack to article page